PMID- 17573415 OWN - NLM STAT- MEDLINE DCOM- 20071026 LR - 20141120 IS - 0958-0670 (Print) IS - 0958-0670 (Linking) VI - 92 IP - 5 DP - 2007 Sep TI - Comparative study of NMDA and AMPA/kainate receptors involved in cardiovascular inhibition produced by imidazoline-like drugs in anaesthetized rats. PG - 849-58 AB - The depressor mechanism of imidazoline-like drugs is believed to result from activation of I(1)-imidazoline receptors (I(1)R) and/or alpha(2)-adrenoceptors within the central nervous system, which are associated with the glutamatergic system. The rostral ventrolateral medulla (RVLM) has been recognized as a specific target area that mediates the depressor action of imidazoline-like drugs. The objective of this study was to determine the comparative effects of blockade of the central glutamate receptor subtypes N-methyl-d-aspartate (NMDA) or alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA)/kainate on the cardiovascular actions of imidazoline-like drugs (clonidine and moxonidine) in anaesthetized rats. Intracerebroventricular (i.c.v.) injection of the NMDA receptor antagonist MK801 or the AMPA/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) produced similar reductions in blood pressure (BP) and heart rate (HR) to those induced by I.C.V. injection of clonidine. Intracerebroventricular injection of the glutamate receptor antagonist kynurenic acid not only abolished clonidine-induced hypotension and bradycardia but converted the responses to a pressor action and tachycardia. Unilateral injection of MK801 or CNQX into RVLM significantly attenuated intra-RVLM clonidine-induced decreases in BP and HR. We also found that unilateral injection of a selective I(1)R agonist, moxonidine, significantly decreased BP and HR, which were also attenuated to a similar extent by prior injection of MK801 or CNQX. In conclusion, these data show that blockade of central (RVLM) NMDA and AMPA/kainate receptors produces similar attenuation of the decrease in BP and HR induced by clonidine or moxonidine. It is suggested that both NMDA and AMPA/kainate receptors are involved in the cardiovascular inhibition produced by imidazoline-like drugs, which is probably at least partly dependent on an I(1)R mechanism in the RVLM. FAU - Wang, Li-Gang AU - Wang LG AD - Department of Physiology, Second Military Medical University, 800 Xiang-Yin Road, Shanghai 200433, China. FAU - Zeng, Jun AU - Zeng J FAU - Yuan, Wen-Jun AU - Yuan WJ FAU - Su, Ding-Feng AU - Su DF FAU - Wang, Wei-Zhong AU - Wang WZ LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20070615 PL - England TA - Exp Physiol JT - Experimental physiology JID - 9002940 RN - 0 (Antihypertensive Agents) RN - 0 (Excitatory Amino Acid Antagonists) RN - 0 (Imidazoles) RN - 0 (Imidazoline Receptors) RN - 0 (Receptors, AMPA) RN - 0 (Receptors, Drug) RN - 0 (Receptors, Glutamate) RN - 0 (Receptors, Kainic Acid) RN - 0 (Receptors, N-Methyl-D-Aspartate) RN - 6LR8C1B66Q (Dizocilpine Maleate) RN - 6OTE87SCCW (6-Cyano-7-nitroquinoxaline-2,3-dione) RN - CC6X0L40GW (moxonidine) RN - H030S2S85J (Kynurenic Acid) RN - MN3L5RMN02 (Clonidine) SB - IM MH - 6-Cyano-7-nitroquinoxaline-2,3-dione/pharmacology MH - Anesthesia MH - Animals MH - Antihypertensive Agents/*pharmacology MH - Blood Pressure/*drug effects/physiology MH - Clonidine/*pharmacology MH - Dizocilpine Maleate/pharmacology MH - Drug Interactions MH - Excitatory Amino Acid Antagonists/pharmacology MH - Heart Rate/*drug effects/physiology MH - Imidazoles/pharmacology MH - Imidazoline Receptors MH - Injections, Intraventricular MH - Kynurenic Acid/pharmacology MH - Male MH - Medulla Oblongata/drug effects/physiology MH - Microinjections MH - Rats MH - Rats, Sprague-Dawley MH - Receptors, AMPA/physiology MH - Receptors, Drug/agonists MH - Receptors, Glutamate/*physiology MH - Receptors, Kainic Acid/physiology MH - Receptors, N-Methyl-D-Aspartate/physiology EDAT- 2007/06/19 09:00 MHDA- 2007/10/30 09:00 CRDT- 2007/06/19 09:00 PHST- 2007/06/19 09:00 [pubmed] PHST- 2007/10/30 09:00 [medline] PHST- 2007/06/19 09:00 [entrez] AID - expphysiol.2007.037861 [pii] AID - 10.1113/expphysiol.2007.037861 [doi] PST - ppublish SO - Exp Physiol. 2007 Sep;92(5):849-58. doi: 10.1113/expphysiol.2007.037861. Epub 2007 Jun 15.